▶ 調査レポート

世界のグラゾプレビル市場2023年:企業・地域・種類・用途別分析

• 英文タイトル:Global Grazoprevir Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

GlobalInfoResearchが調査・発行した産業分析レポートです。世界のグラゾプレビル市場2023年:企業・地域・種類・用途別分析 / Global Grazoprevir Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029 / MRC308GR11398資料のイメージです。• レポートコード:MRC308GR11398
• 出版社/出版日:GlobalInfoResearch / 2023年8月12日
• レポート形態:英文、PDF、94ページ
• 納品方法:Eメール(2-3営業日)
• 産業分類:医薬品&ヘルスケア
• 販売価格(消費税別)
  Single User¥504,600 (USD3,480)▷ お問い合わせ
  Corporate User¥756,900 (USD5,220)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要

GlobalInfoResearchの最新の調査によると、世界のグラゾプレビルの市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx%の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界のグラゾプレビル市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。

市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。

本レポートの主な目的は次のとおりです。
– 世界および主要国の市場機会の規模を決定するため
– グラゾプレビルの成長可能性を評価するため
– 各製品および最終用途市場の将来の成長を予測するため
– 市場に影響を与える競争要因を評価するため

グラゾプレビル市場は種類と用途によって区分されます。2018年~2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメント
・50mg、100mg

用途別セグメント
・病院、ドラッグストア&薬局

主要な市場プレーヤー
・Gilead sciences、Abbvie、Johnson and Johnson、Merck、GlaxoSmithKline、Novartis、Bristol-Myers Squibb、Hoffmann-la Roche

地域別セグメントは次の地域・国をカバーします。
・北米(米国、カナダ、メキシコ)
・ヨーロッパ(ドイツ、フランス、イギリス、ロシア、イタリア)
・アジア太平洋(日本、中国、韓国、インド、東南アジア、オーストラリア)
・南アメリカ(ブラジル、アルゼンチン、コロンビア)
・中東およびアフリカ(サウジアラビア、UAE、エジプト、南アフリカ)

本調査レポートの内容は計15章あります。
・第1章では、グラゾプレビル製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なグラゾプレビルメーカーの企業概要、2019年~2022年までのグラゾプレビルの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なグラゾプレビルメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年~2029年までの地域別グラゾプレビルの販売量、売上、成長性を示しています。
・第5、6章では、2018年~2029年までのグラゾプレビルの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年~2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年~2029年までの主要地域でのグラゾプレビル市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、およびグラゾプレビルの産業チェーンを掲載しています。
・第14、15章では、グラゾプレビルの販売チャネル、販売業者、顧客、調査結果について説明します。

***** 目次(一部) *****

・市場概要
– グラゾプレビルの概要
– 種類別分析(2018年vs2022年vs2029年):50mg、100mg
– 用途別分析(2018年vs2022年vs2029年):病院、ドラッグストア&薬局
– 世界のグラゾプレビル市場規模・予測
– 世界のグラゾプレビル生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報(企業概要、製品概要、販売量、価格、売上)
– Gilead sciences、Abbvie、Johnson and Johnson、Merck、GlaxoSmithKline、Novartis、Bristol-Myers Squibb、Hoffmann-la Roche
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・種類別分析2018年-2029年:50mg、100mg
・用途別分析2018年-2029年:病院、ドラッグストア&薬局
・グラゾプレビルの北米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模:アメリカ、カナダ、メキシコなど
・グラゾプレビルのヨーロッパ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模:ドイツ、イギリス、フランス、ロシア、イタリアなど
・グラゾプレビルのアジア市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模:中国、日本、韓国、インド、東南アジア、オーストラリアなど
・グラゾプレビルの南米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模:ブラジル、アルゼンチンなど
・グラゾプレビルの中東・アフリカ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模:サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学(成長要因、阻害要因、トレンド、ポーターズファイブフォース分析)
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

レポート目次

1 Market Overview
1.1 Product Overview and Scope of Grazoprevir
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Grazoprevir Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 50 mg
1.3.3 100 mg
1.4 Market Analysis by Application
1.4.1 Overview: Global Grazoprevir Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospitals
1.4.3 Drug Stores/ Pharmacies
1.5 Global Grazoprevir Market Size & Forecast
1.5.1 Global Grazoprevir Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Grazoprevir Sales Quantity (2018-2029)
1.5.3 Global Grazoprevir Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Gilead sciences
2.1.1 Gilead sciences Details
2.1.2 Gilead sciences Major Business
2.1.3 Gilead sciences Grazoprevir Product and Services
2.1.4 Gilead sciences Grazoprevir Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Gilead sciences Recent Developments/Updates
2.2 Abbvie
2.2.1 Abbvie Details
2.2.2 Abbvie Major Business
2.2.3 Abbvie Grazoprevir Product and Services
2.2.4 Abbvie Grazoprevir Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Abbvie Recent Developments/Updates
2.3 Johnson and Johnson
2.3.1 Johnson and Johnson Details
2.3.2 Johnson and Johnson Major Business
2.3.3 Johnson and Johnson Grazoprevir Product and Services
2.3.4 Johnson and Johnson Grazoprevir Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Johnson and Johnson Recent Developments/Updates
2.4 Merck
2.4.1 Merck Details
2.4.2 Merck Major Business
2.4.3 Merck Grazoprevir Product and Services
2.4.4 Merck Grazoprevir Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Merck Recent Developments/Updates
2.5 GlaxoSmithKline
2.5.1 GlaxoSmithKline Details
2.5.2 GlaxoSmithKline Major Business
2.5.3 GlaxoSmithKline Grazoprevir Product and Services
2.5.4 GlaxoSmithKline Grazoprevir Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 GlaxoSmithKline Recent Developments/Updates
2.6 Novartis
2.6.1 Novartis Details
2.6.2 Novartis Major Business
2.6.3 Novartis Grazoprevir Product and Services
2.6.4 Novartis Grazoprevir Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Novartis Recent Developments/Updates
2.7 Bristol-Myers Squibb
2.7.1 Bristol-Myers Squibb Details
2.7.2 Bristol-Myers Squibb Major Business
2.7.3 Bristol-Myers Squibb Grazoprevir Product and Services
2.7.4 Bristol-Myers Squibb Grazoprevir Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Bristol-Myers Squibb Recent Developments/Updates
2.8 Hoffmann-la Roche
2.8.1 Hoffmann-la Roche Details
2.8.2 Hoffmann-la Roche Major Business
2.8.3 Hoffmann-la Roche Grazoprevir Product and Services
2.8.4 Hoffmann-la Roche Grazoprevir Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Hoffmann-la Roche Recent Developments/Updates
3 Competitive Environment: Grazoprevir by Manufacturer
3.1 Global Grazoprevir Sales Quantity by Manufacturer (2018-2023)
3.2 Global Grazoprevir Revenue by Manufacturer (2018-2023)
3.3 Global Grazoprevir Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Grazoprevir by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Grazoprevir Manufacturer Market Share in 2022
3.4.2 Top 6 Grazoprevir Manufacturer Market Share in 2022
3.5 Grazoprevir Market: Overall Company Footprint Analysis
3.5.1 Grazoprevir Market: Region Footprint
3.5.2 Grazoprevir Market: Company Product Type Footprint
3.5.3 Grazoprevir Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Grazoprevir Market Size by Region
4.1.1 Global Grazoprevir Sales Quantity by Region (2018-2029)
4.1.2 Global Grazoprevir Consumption Value by Region (2018-2029)
4.1.3 Global Grazoprevir Average Price by Region (2018-2029)
4.2 North America Grazoprevir Consumption Value (2018-2029)
4.3 Europe Grazoprevir Consumption Value (2018-2029)
4.4 Asia-Pacific Grazoprevir Consumption Value (2018-2029)
4.5 South America Grazoprevir Consumption Value (2018-2029)
4.6 Middle East and Africa Grazoprevir Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Grazoprevir Sales Quantity by Type (2018-2029)
5.2 Global Grazoprevir Consumption Value by Type (2018-2029)
5.3 Global Grazoprevir Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Grazoprevir Sales Quantity by Application (2018-2029)
6.2 Global Grazoprevir Consumption Value by Application (2018-2029)
6.3 Global Grazoprevir Average Price by Application (2018-2029)
7 North America
7.1 North America Grazoprevir Sales Quantity by Type (2018-2029)
7.2 North America Grazoprevir Sales Quantity by Application (2018-2029)
7.3 North America Grazoprevir Market Size by Country
7.3.1 North America Grazoprevir Sales Quantity by Country (2018-2029)
7.3.2 North America Grazoprevir Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Grazoprevir Sales Quantity by Type (2018-2029)
8.2 Europe Grazoprevir Sales Quantity by Application (2018-2029)
8.3 Europe Grazoprevir Market Size by Country
8.3.1 Europe Grazoprevir Sales Quantity by Country (2018-2029)
8.3.2 Europe Grazoprevir Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Grazoprevir Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Grazoprevir Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Grazoprevir Market Size by Region
9.3.1 Asia-Pacific Grazoprevir Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Grazoprevir Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Grazoprevir Sales Quantity by Type (2018-2029)
10.2 South America Grazoprevir Sales Quantity by Application (2018-2029)
10.3 South America Grazoprevir Market Size by Country
10.3.1 South America Grazoprevir Sales Quantity by Country (2018-2029)
10.3.2 South America Grazoprevir Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Grazoprevir Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Grazoprevir Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Grazoprevir Market Size by Country
11.3.1 Middle East & Africa Grazoprevir Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Grazoprevir Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Grazoprevir Market Drivers
12.2 Grazoprevir Market Restraints
12.3 Grazoprevir Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Grazoprevir and Key Manufacturers
13.2 Manufacturing Costs Percentage of Grazoprevir
13.3 Grazoprevir Production Process
13.4 Grazoprevir Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Grazoprevir Typical Distributors
14.3 Grazoprevir Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

List of Tables
Table 1. Global Grazoprevir Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Grazoprevir Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Gilead sciences Basic Information, Manufacturing Base and Competitors
Table 4. Gilead sciences Major Business
Table 5. Gilead sciences Grazoprevir Product and Services
Table 6. Gilead sciences Grazoprevir Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Gilead sciences Recent Developments/Updates
Table 8. Abbvie Basic Information, Manufacturing Base and Competitors
Table 9. Abbvie Major Business
Table 10. Abbvie Grazoprevir Product and Services
Table 11. Abbvie Grazoprevir Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Abbvie Recent Developments/Updates
Table 13. Johnson and Johnson Basic Information, Manufacturing Base and Competitors
Table 14. Johnson and Johnson Major Business
Table 15. Johnson and Johnson Grazoprevir Product and Services
Table 16. Johnson and Johnson Grazoprevir Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Johnson and Johnson Recent Developments/Updates
Table 18. Merck Basic Information, Manufacturing Base and Competitors
Table 19. Merck Major Business
Table 20. Merck Grazoprevir Product and Services
Table 21. Merck Grazoprevir Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Merck Recent Developments/Updates
Table 23. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 24. GlaxoSmithKline Major Business
Table 25. GlaxoSmithKline Grazoprevir Product and Services
Table 26. GlaxoSmithKline Grazoprevir Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. GlaxoSmithKline Recent Developments/Updates
Table 28. Novartis Basic Information, Manufacturing Base and Competitors
Table 29. Novartis Major Business
Table 30. Novartis Grazoprevir Product and Services
Table 31. Novartis Grazoprevir Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Novartis Recent Developments/Updates
Table 33. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 34. Bristol-Myers Squibb Major Business
Table 35. Bristol-Myers Squibb Grazoprevir Product and Services
Table 36. Bristol-Myers Squibb Grazoprevir Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Bristol-Myers Squibb Recent Developments/Updates
Table 38. Hoffmann-la Roche Basic Information, Manufacturing Base and Competitors
Table 39. Hoffmann-la Roche Major Business
Table 40. Hoffmann-la Roche Grazoprevir Product and Services
Table 41. Hoffmann-la Roche Grazoprevir Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Hoffmann-la Roche Recent Developments/Updates
Table 43. Global Grazoprevir Sales Quantity by Manufacturer (2018-2023) & (Kg)
Table 44. Global Grazoprevir Revenue by Manufacturer (2018-2023) & (USD Million)
Table 45. Global Grazoprevir Average Price by Manufacturer (2018-2023) & (US$/Kg)
Table 46. Market Position of Manufacturers in Grazoprevir, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 47. Head Office and Grazoprevir Production Site of Key Manufacturer
Table 48. Grazoprevir Market: Company Product Type Footprint
Table 49. Grazoprevir Market: Company Product Application Footprint
Table 50. Grazoprevir New Market Entrants and Barriers to Market Entry
Table 51. Grazoprevir Mergers, Acquisition, Agreements, and Collaborations
Table 52. Global Grazoprevir Sales Quantity by Region (2018-2023) & (Kg)
Table 53. Global Grazoprevir Sales Quantity by Region (2024-2029) & (Kg)
Table 54. Global Grazoprevir Consumption Value by Region (2018-2023) & (USD Million)
Table 55. Global Grazoprevir Consumption Value by Region (2024-2029) & (USD Million)
Table 56. Global Grazoprevir Average Price by Region (2018-2023) & (US$/Kg)
Table 57. Global Grazoprevir Average Price by Region (2024-2029) & (US$/Kg)
Table 58. Global Grazoprevir Sales Quantity by Type (2018-2023) & (Kg)
Table 59. Global Grazoprevir Sales Quantity by Type (2024-2029) & (Kg)
Table 60. Global Grazoprevir Consumption Value by Type (2018-2023) & (USD Million)
Table 61. Global Grazoprevir Consumption Value by Type (2024-2029) & (USD Million)
Table 62. Global Grazoprevir Average Price by Type (2018-2023) & (US$/Kg)
Table 63. Global Grazoprevir Average Price by Type (2024-2029) & (US$/Kg)
Table 64. Global Grazoprevir Sales Quantity by Application (2018-2023) & (Kg)
Table 65. Global Grazoprevir Sales Quantity by Application (2024-2029) & (Kg)
Table 66. Global Grazoprevir Consumption Value by Application (2018-2023) & (USD Million)
Table 67. Global Grazoprevir Consumption Value by Application (2024-2029) & (USD Million)
Table 68. Global Grazoprevir Average Price by Application (2018-2023) & (US$/Kg)
Table 69. Global Grazoprevir Average Price by Application (2024-2029) & (US$/Kg)
Table 70. North America Grazoprevir Sales Quantity by Type (2018-2023) & (Kg)
Table 71. North America Grazoprevir Sales Quantity by Type (2024-2029) & (Kg)
Table 72. North America Grazoprevir Sales Quantity by Application (2018-2023) & (Kg)
Table 73. North America Grazoprevir Sales Quantity by Application (2024-2029) & (Kg)
Table 74. North America Grazoprevir Sales Quantity by Country (2018-2023) & (Kg)
Table 75. North America Grazoprevir Sales Quantity by Country (2024-2029) & (Kg)
Table 76. North America Grazoprevir Consumption Value by Country (2018-2023) & (USD Million)
Table 77. North America Grazoprevir Consumption Value by Country (2024-2029) & (USD Million)
Table 78. Europe Grazoprevir Sales Quantity by Type (2018-2023) & (Kg)
Table 79. Europe Grazoprevir Sales Quantity by Type (2024-2029) & (Kg)
Table 80. Europe Grazoprevir Sales Quantity by Application (2018-2023) & (Kg)
Table 81. Europe Grazoprevir Sales Quantity by Application (2024-2029) & (Kg)
Table 82. Europe Grazoprevir Sales Quantity by Country (2018-2023) & (Kg)
Table 83. Europe Grazoprevir Sales Quantity by Country (2024-2029) & (Kg)
Table 84. Europe Grazoprevir Consumption Value by Country (2018-2023) & (USD Million)
Table 85. Europe Grazoprevir Consumption Value by Country (2024-2029) & (USD Million)
Table 86. Asia-Pacific Grazoprevir Sales Quantity by Type (2018-2023) & (Kg)
Table 87. Asia-Pacific Grazoprevir Sales Quantity by Type (2024-2029) & (Kg)
Table 88. Asia-Pacific Grazoprevir Sales Quantity by Application (2018-2023) & (Kg)
Table 89. Asia-Pacific Grazoprevir Sales Quantity by Application (2024-2029) & (Kg)
Table 90. Asia-Pacific Grazoprevir Sales Quantity by Region (2018-2023) & (Kg)
Table 91. Asia-Pacific Grazoprevir Sales Quantity by Region (2024-2029) & (Kg)
Table 92. Asia-Pacific Grazoprevir Consumption Value by Region (2018-2023) & (USD Million)
Table 93. Asia-Pacific Grazoprevir Consumption Value by Region (2024-2029) & (USD Million)
Table 94. South America Grazoprevir Sales Quantity by Type (2018-2023) & (Kg)
Table 95. South America Grazoprevir Sales Quantity by Type (2024-2029) & (Kg)
Table 96. South America Grazoprevir Sales Quantity by Application (2018-2023) & (Kg)
Table 97. South America Grazoprevir Sales Quantity by Application (2024-2029) & (Kg)
Table 98. South America Grazoprevir Sales Quantity by Country (2018-2023) & (Kg)
Table 99. South America Grazoprevir Sales Quantity by Country (2024-2029) & (Kg)
Table 100. South America Grazoprevir Consumption Value by Country (2018-2023) & (USD Million)
Table 101. South America Grazoprevir Consumption Value by Country (2024-2029) & (USD Million)
Table 102. Middle East & Africa Grazoprevir Sales Quantity by Type (2018-2023) & (Kg)
Table 103. Middle East & Africa Grazoprevir Sales Quantity by Type (2024-2029) & (Kg)
Table 104. Middle East & Africa Grazoprevir Sales Quantity by Application (2018-2023) & (Kg)
Table 105. Middle East & Africa Grazoprevir Sales Quantity by Application (2024-2029) & (Kg)
Table 106. Middle East & Africa Grazoprevir Sales Quantity by Region (2018-2023) & (Kg)
Table 107. Middle East & Africa Grazoprevir Sales Quantity by Region (2024-2029) & (Kg)
Table 108. Middle East & Africa Grazoprevir Consumption Value by Region (2018-2023) & (USD Million)
Table 109. Middle East & Africa Grazoprevir Consumption Value by Region (2024-2029) & (USD Million)
Table 110. Grazoprevir Raw Material
Table 111. Key Manufacturers of Grazoprevir Raw Materials
Table 112. Grazoprevir Typical Distributors
Table 113. Grazoprevir Typical Customers
List of Figures
Figure 1. Grazoprevir Picture
Figure 2. Global Grazoprevir Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Grazoprevir Consumption Value Market Share by Type in 2022
Figure 4. 50 mg Examples
Figure 5. 100 mg Examples
Figure 6. Global Grazoprevir Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Grazoprevir Consumption Value Market Share by Application in 2022
Figure 8. Hospitals Examples
Figure 9. Drug Stores/ Pharmacies Examples
Figure 10. Global Grazoprevir Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global Grazoprevir Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Grazoprevir Sales Quantity (2018-2029) & (Kg)
Figure 13. Global Grazoprevir Average Price (2018-2029) & (US$/Kg)
Figure 14. Global Grazoprevir Sales Quantity Market Share by Manufacturer in 2022
Figure 15. Global Grazoprevir Consumption Value Market Share by Manufacturer in 2022
Figure 16. Producer Shipments of Grazoprevir by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 17. Top 3 Grazoprevir Manufacturer (Consumption Value) Market Share in 2022
Figure 18. Top 6 Grazoprevir Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Global Grazoprevir Sales Quantity Market Share by Region (2018-2029)
Figure 20. Global Grazoprevir Consumption Value Market Share by Region (2018-2029)
Figure 21. North America Grazoprevir Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe Grazoprevir Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific Grazoprevir Consumption Value (2018-2029) & (USD Million)
Figure 24. South America Grazoprevir Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East & Africa Grazoprevir Consumption Value (2018-2029) & (USD Million)
Figure 26. Global Grazoprevir Sales Quantity Market Share by Type (2018-2029)
Figure 27. Global Grazoprevir Consumption Value Market Share by Type (2018-2029)
Figure 28. Global Grazoprevir Average Price by Type (2018-2029) & (US$/Kg)
Figure 29. Global Grazoprevir Sales Quantity Market Share by Application (2018-2029)
Figure 30. Global Grazoprevir Consumption Value Market Share by Application (2018-2029)
Figure 31. Global Grazoprevir Average Price by Application (2018-2029) & (US$/Kg)
Figure 32. North America Grazoprevir Sales Quantity Market Share by Type (2018-2029)
Figure 33. North America Grazoprevir Sales Quantity Market Share by Application (2018-2029)
Figure 34. North America Grazoprevir Sales Quantity Market Share by Country (2018-2029)
Figure 35. North America Grazoprevir Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Grazoprevir Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 37. Canada Grazoprevir Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Mexico Grazoprevir Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Europe Grazoprevir Sales Quantity Market Share by Type (2018-2029)
Figure 40. Europe Grazoprevir Sales Quantity Market Share by Application (2018-2029)
Figure 41. Europe Grazoprevir Sales Quantity Market Share by Country (2018-2029)
Figure 42. Europe Grazoprevir Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany Grazoprevir Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. France Grazoprevir Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. United Kingdom Grazoprevir Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Russia Grazoprevir Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Italy Grazoprevir Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Asia-Pacific Grazoprevir Sales Quantity Market Share by Type (2018-2029)
Figure 49. Asia-Pacific Grazoprevir Sales Quantity Market Share by Application (2018-2029)
Figure 50. Asia-Pacific Grazoprevir Sales Quantity Market Share by Region (2018-2029)
Figure 51. Asia-Pacific Grazoprevir Consumption Value Market Share by Region (2018-2029)
Figure 52. China Grazoprevir Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Japan Grazoprevir Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Korea Grazoprevir Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. India Grazoprevir Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Southeast Asia Grazoprevir Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Australia Grazoprevir Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. South America Grazoprevir Sales Quantity Market Share by Type (2018-2029)
Figure 59. South America Grazoprevir Sales Quantity Market Share by Application (2018-2029)
Figure 60. South America Grazoprevir Sales Quantity Market Share by Country (2018-2029)
Figure 61. South America Grazoprevir Consumption Value Market Share by Country (2018-2029)
Figure 62. Brazil Grazoprevir Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Argentina Grazoprevir Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Middle East & Africa Grazoprevir Sales Quantity Market Share by Type (2018-2029)
Figure 65. Middle East & Africa Grazoprevir Sales Quantity Market Share by Application (2018-2029)
Figure 66. Middle East & Africa Grazoprevir Sales Quantity Market Share by Region (2018-2029)
Figure 67. Middle East & Africa Grazoprevir Consumption Value Market Share by Region (2018-2029)
Figure 68. Turkey Grazoprevir Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Egypt Grazoprevir Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Saudi Arabia Grazoprevir Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. South Africa Grazoprevir Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Grazoprevir Market Drivers
Figure 73. Grazoprevir Market Restraints
Figure 74. Grazoprevir Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Grazoprevir in 2022
Figure 77. Manufacturing Process Analysis of Grazoprevir
Figure 78. Grazoprevir Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source